author-photo

Gretja Schnell

University of North Carolina at Chapel Hill

43

Papers

2010

Citations

Citation Trend

Filter By

Papers (35) Sort By

Journal Conference Others

Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)

2019
Show All
- Source
- Cite
- Save
Citations (0)
IDDF2019-ABS-0211 Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5 or 6 infection: an integrated analysis of phase 2 and 3 studies

2019 Gut
Show All
- Source
- Cite
- Save
Citations (0)
THU-194-Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5 or 6 infection: An integrated analysis of phase 2 and 3 studies

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir

2018 Journal of Medical Virology
Show All
- Source
- Cite
- Save
Citations (12)
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (7)
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

2018 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (5)
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials

2018 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (51)
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

2018 Viruses
Show All
- Source
- Cite
- Save
Citations (2)
Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4‐infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavir

2018 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (3)
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

2017 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (100)